NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., June 28, 2023 /PRNewswire/ — DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that the data related to analytical validation of the company’s 24 microRNA panel for risk assessment of Alzheimer’s disease, CogniMIR®, has been published in the journal Diagnostics.

Titled “Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment,” an online version of this manuscript can be found at https://www.mdpi.com/2075-4418/13/13/2170.